CG
AGIO icon

Cutler Group’s Agios Pharmaceuticals AGIO Stock Holding History

Cutler Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,000
Closed -$6K – 3699
2022
Q4 		$6K Sell
4,000
-4,000
-50% -$113K ﹤0.01% 3008
2022
Q3 		$44K Buy
8,000
+4,000
+100% +$107K ﹤0.01% 1980
2022
Q2 		$14K Buy
+4,000
New +$90.3K ﹤0.01% 2926
2021
Q2 		– Sell
-10,200
Closed -$24K – 5596
2021
Q1 		$24K Buy
10,200
+7,700
+308% +$381K ﹤0.01% 3051
2020
Q4 		$4K Buy
+2,500
New +$98.8K ﹤0.01% 3743
2020
Q2 		– Sell
-10,200
Closed -$40K – 4304
2020
Q1 		$40K Buy
10,200
+9,900
+3,300% +$457K ﹤0.01% 1857
2019
Q4 		$2K Buy
+300
New +$11.3K ﹤0.01% 3387
2018
Q3 		– Sell
-3,100
Closed -$37K – 4026
2018
Q2 		$37K Buy
3,100
+100
+3% +$8.72K ﹤0.01% 1786
2018
Q1 		$41K Buy
+3,000
New +$232K ﹤0.01% 1794
2017
Q4 		– Sell
-4,300
Closed -$29K – 4785
2017
Q3 		$29K Buy
4,300
+500
+13% +$30K ﹤0.01% 2761
2017
Q2 		$11K Sell
3,800
-36,700
-91% -$1.88M ﹤0.01% 4038
2017
Q1 		$139K Sell
40,500
-7,600
-16% -$364K 0.01% 1464
2016
Q4 		$126K Buy
48,100
+5,200
+12% +$273K ﹤0.01% 1692
2016
Q3 		$244K Buy
42,900
+25,200
+142% +$1.1M 0.01% 1051
2016
Q2 		$59K Buy
17,700
+8,300
+88% +$410K ﹤0.01% 2185
2016
Q1 		$7K Sell
9,400
-7,400
-44% -$316K ﹤0.01% 4430
2015
Q4 		$143K Buy
+16,800
New +$1.1M 0.01% 1454

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cutler Group's AGIO Position: Q1 2024 in Review

Cutler Group increased its Agios Pharmaceuticals (AGIO) stake by 1.9% in Q1 2024, buying an estimated $3.48K and bringing the position to 7,130 shares worth $208K. The position accounts for 0.07% of the portfolio, ranked #273.

Cutler Group first reported a position in AGIO in Q4 2015 and has held it in 33 quarters since. The position peaked at $1.14M in Q3 2016. 187 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Cutler Group held 7,130 shares of Agios Pharmaceuticals worth $208K as of Q1 2024.
  • Cutler Group bought 130 Agios Pharmaceuticals shares in Q1 2024, an estimated $3.48K.
  • Agios Pharmaceuticals made up 0.07% of Cutler Group's portfolio in Q1 2024, its #273 holding.
  • Cutler Group first reported a position in Agios Pharmaceuticals in Q4 2015 and has held it in 33 quarters since.
  • Cutler Group's Agios Pharmaceuticals position peaked at $1.14M in Q3 2016.
  • 187 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.